Generic substitution: are antiepileptic drugs different?

被引：0
|
作者：
Carl W. Bazil
机构：
[1] Columbia University,Department of Neurology
来源：
Nature Reviews Neurology | 2009年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Generic drug substitution can markedly decrease the cost of health care. For conditions where agents have a relatively narrow therapeutic index, notably epilepsy, financial savings through generic substitution might be offset by increases in patient complications and related costs. Results from a study with topiramate support this view, particularly when a patient receives a drug from multiple manufacturers.
引用
收藏
页码：587 / 588
页数：1
相关论文
共 50 条
  • [1] EPILEPSY Generic substitution: are antiepileptic drugs different?
    Bazil, Carl W.
    [J]. NATURE REVIEWS NEUROLOGY, 2009, 5 (11) : 587 - 588
  • [2] Generic substitution of antiepileptic drugs
    Sander, Josemir W.
    Ryvlin, Philippe
    Stefan, Hermann
    Booth, Daniel R.
    Bauer, Juergen
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1887 - 1898
  • [3] Antiepileptic drugs: the drawbacks of generic substitution
    不详
    [J]. LANCET NEUROLOGY, 2010, 9 (03): : 227 - 227
  • [4] Generic Substitution of Antiepileptic Drugs: A Telephone Survey
    Yamada, Mikiko
    Welty, Timothy E.
    [J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (05) : 938 - 939
  • [5] EXPERIENCES IN GENERIC SUBSTITUTION OF ANTIEPILEPTIC DRUGS IN TAIWAN
    Hsieh, L.
    Tsai, J.
    Yu, H.
    Chi, J.
    [J]. EPILEPSIA, 2009, 50 : 97 - 97
  • [6] Pharmacy and generic substitution of antiepileptic drugs: Missing in action?
    Welty, Timothy E.
    [J]. ANNALS OF PHARMACOTHERAPY, 2007, 41 (06) : 1065 - 1068
  • [7] Generic substitution for brand name antiepileptic drugs: A survey
    Guberman, A
    Corman, C
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2000, 27 (01) : 37 - 43
  • [8] AES Position Statement on Generic Substitution of Antiepileptic Drugs
    Vossler, David G.
    Anderson, Gail D.
    Bainbridge, Jacquelyn
    [J]. EPILEPSY CURRENTS, 2016, 16 (03) : 209 - 211
  • [9] The risks of multiple generic substitution of antiepileptic drugs : The case of topiramate
    Lelorier, J.
    Duh, M. S.
    Paradis, P. E.
    Latremouille-Viau, D.
    Sheehy, O.
    Greenberg, P.
    Lee, S. P.
    Rupnow, M. F.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A151 - A151
  • [10] Comment: Pharmacy and generic substitution of Antiepileptic drugs: Missing in action?
    Hatton, Randy C.
    [J]. ANNALS OF PHARMACOTHERAPY, 2007, 41 (09) : 1550 - 1551
12345